Rachel Lenington, Chief Operating Officer at Athira Pharma, Inc. (ATHA), sold 4,193 shares at $2.69 ($11K) on 2022-06-23, disclosed to the SEC on 2022-06-24.
Open-market sale of $11k ATHA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |